EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
European Shares Seen Mostly Higher In Cautious Trade
AstraZeneca (NASDAQ:AZN) Sets New 1-Year High - What's Next?
Is China's ENHERTU Approval in HR-positive HER2-low Breast Cancer Altering The Investment Case For Daiichi Sankyo Company (TSE:4568)?
Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990-2023: a Global Burden of Disease study
AstraZeneca PLC $AZN Stake Boosted by Allspring Global Investments Holdings LLC
The actionable transcriptome: a framework for incorporating RNA sequencing into precision oncology
Neoadjuvant immune checkpoint blockade before chemoradiation for cervical squamous carcinoma (GINECO window-of-opportunity COLIBRI study): a phase II trial
Taking Stock of AstraZeneca (LSE:AZN): Is Its 31% One-Year Return Now Fully Valued?
AstraZeneca (NASDAQ:AZN) Upgraded to Strong-Buy at Wall Street Zen
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
Q4 EPS Estimates for AstraZeneca Boosted by Zacks Research
Optimizing cardiovascular pharmacotherapy in older adults with frailty
My Personal CFO LLC Acquires Shares of 38,411 AstraZeneca PLC $AZN
I asked ChatGPT for its top FTSE 100 stock for 2026, and it said…
Zacks Research Raises Earnings Estimates for AstraZeneca - Stock Observer
25,322 Shares in AstraZeneca PLC $AZN Purchased by Moody Lynn & Lieberson LLC
Smith Salley Wealth Management Raises Stock Holdings in AstraZeneca PLC $AZN
Ethic Inc. Acquires 11,638 Shares of AstraZeneca PLC $AZN
Regulatory actions for Dec. 30, 2025 | BioWorld
DAVENPORT & Co LLC Increases Stake in AstraZeneca PLC $AZN
China's rising biotech clout on show in flurry of billion-dollar licensing deals | South China Morning Post
Robbins Farley Purchases 27,582 Shares of AstraZeneca PLC $AZN
Jacobio, AstraZeneca ink cancer drug deal - Chinadaily.com.cn
AstraZeneca Reaches Settlement With MSN Labs Over Cancer Drug
Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications
Pharma Giants Compete to Unveil First Effective Weight-Loss Pill, ETPharma
Factbox-Top pharma companies racing to launch first weight-loss pill
Did ChatGPT give me the best FTSE stocks to buy 1 year ago?
Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial
)
Cambridge Cluster companies build global status and hook more than $2 billion funding in 2025
Health Care Up as Traders Rotate Back Into Sector - Health Care Roundup | Morningstar
AstraZeneca Sues US Over Drugs for Medicare Price Cuts Round 2
AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock - Markets Daily
AstraZeneca (LON:AZN) Insider Sells £40,083.12 in Stock
AstraZeneca's Ceralasertib-Imfinzi Combination Fails Lung Cancer Trial, ETPharma
Jacobio signs $1.9B deal with Astrazeneca for pan-KRAS inhibitor | BioWorld
Jacobio licenses pan KRAS inhibitor to AstraZeneca
China's Jacobio inks immuno-oncology deal worth $1.9 B with AstraZeneca
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial
Jacobio Pharma Signs Agreement With AstraZeneca On Pan-KRAS Inhibitor JAB-23E73
AstraZeneca PLC $AZN Position Boosted by Benson Investment Management Company Inc.
Flputnam Investment Management Co. Increases Holdings in AstraZeneca PLC $AZN - Daily Political
Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases
AstraZeneca Unit Gets Partial Win in Soliris Drug Monopoly Case
AstraZeneca PLC (AZN) Announces Approval of Saphnelo by the European Union
16,277 Shares in AstraZeneca PLC $AZN Bought by Montecito Bank & Trust
Voya Investment Management LLC Buys 770,417 Shares of AstraZeneca PLC $AZN - Daily Political
AstraZeneca's Breast Cancer Drug Datopotamab Deruxtecan Approved in India, ETPharma
15 stocks to watch on Friday: Lupin, Ola, AstraZeneca, Shriram Finance
AstraZeneca Fails to Block Colorado Contract Pharmacy Regulation
Assenagon Asset Management S.A. Sells 569,162 Shares of AstraZeneca PLC $AZN
10 Newly Overvalued Stocks this Month | Morningstar Nordics
The Bull Case For Salesforce (CRM) Could Change Following Broad Agentforce 360 Wins Across Key Sectors
Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets
Rep. Gilbert Ray Cisneros, Jr. Buys AstraZeneca PLC (NASDAQ:AZN) Stock
Sanders Morris Harris LLC Invests $950,000 in AstraZeneca PLC $AZN
B. Riley Wealth Advisors Inc. Invests $776,000 in AstraZeneca PLC $AZN
Recent Investment Analysts' Ratings Updates for AstraZeneca (AZN) - Markets Daily
University announces new partnership with AstraZeneca and Beijing municipal parties to accelerate innovations in healthcare | PressReleasePoint
AstraZeneca PLC ADRhedged (BATS:AZNH) Declares $0.58 Annual Dividend - Markets Daily
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of "Moderate Buy" from Analysts
AstraZeneca Announces Approval Of Saphnelo In The EU
AstraZeneca PLC $AZN Shares Acquired by Park National Corp OH - Stock Observer
AstraZeneca, Daiichi Sankyo's Enhertu Regimen Greenlit as First-line Breast Cancer Treatment in US
Beyfortus (Nirsevimab) now available in Malaysia to help protect all infants against RSV disease | Malay Mail
FDA Approves Enhertu and Perjeta Combination for First-Line HER2-Positive Breast Cancer Treatment, ETPharma
Extranodal extension in lung adenocarcinoma: pathological insights and its implication as a histological marker of clinical aggressiveness
Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI models
Based on DESTINY-Breast09 Phase III trial results that showe
Geneos Wealth Management Inc. Grows Stock Holdings in AstraZeneca PLC $AZN
US senators want the lowdown on Trump biopharma pricing deals | BioWorld
Health Innovation Hub: accelerating health equity through digital healthcare innovation
The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer
AZN: Oncology Execution And US Manufacturing Expansion Will Drive Long-Term Upside Potential
AstraZeneca PLC $AZN Shares Bought by Cubist Systematic Strategies LLC - Markets Daily
AstraZeneca PLC $AZN Shares Bought by BI Asset Management Fondsmaeglerselskab A S
Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer
Clinical outcome and proportion of hereditary cancer genes gPV in TNBC: the HEaRTBeat study
AstraZeneca (AZN) At the Center of Serious Analyst Attention
AstraZeneca (LON:AZN) Share Price Crosses Above 200-Day Moving Average - Should You Sell?
Parkwood LLC Raises Stock Holdings in AstraZeneca PLC $AZN - Stock Observer
Astrazeneca reports data on AZD-4512 for B-cell malignancies | BioWorld
Clinical characteristics and prognostic impact of HER2 low expression in breast cancer subtypes from a Brazilian real-world cohort
Democratic senators demand details on Trump's drugmaker deals | TribLIVE.com
Top Pharmaceutical Stocks To Keep An Eye On - December 11th - Daily Political
AstraZeneca, its China joint fund lead nearly $100m financing in Syneron Bio
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Acquires 36,387 Shares of AstraZeneca PLC $AZN - Daily Political
Why is AstraZeneca PLC (AZN) One of the Best Pharma Stocks to Invest In?
60,378 Shares in AstraZeneca PLC $AZN Bought by Norges Bank
Non-Hodgkin Lymphoma Clinical Trial Pipeline Accelerates as 180+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
